v3.26.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
 [1]
Current Assets:    
Cash and cash equivalents $ 3,823 $ 5,894
Short-term investments 17,285 14,487
Prepaid expenses and other current assets 228 519
Total current assets 21,336 20,900
In-process research and development asset 8,819 8,819
Total assets 30,155 29,719
Current Liabilities:    
Accounts payable 927 544
Accrued and other liabilities 2,448 2,615
Liabilities of discontinued operations 650 650
Total current liabilities 4,025 3,809
Warrant liability 1,153 2,376
Liability related to the sale of future payments 6,499 6,499
Total liabilities 11,677 12,684
Commitments and Contingencies  
Stockholders’ Equity:    
Common stock, $0.001 par value—200,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 50,049,824 and 49,328,097 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 50 49
Additional paid-in capital 492,504 488,506
Accumulated deficit (474,076) (471,520)
Total stockholders’ equity 18,478 17,035
Total Liabilities and Stockholders’ Equity $ 30,155 $ 29,719
[1] The condensed consolidated balance sheet as of December 31, 2025 has been derived from the audited financial statements as of that date included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.